Aller au contenu

514 606-3350

info@cliniqueomicron.ca​

FR / EN
Logo - Clinique Omicron
Make an appointment
Colorectal Surgery & Gastroenterology & Family Medicine

Anal fissure

Get advice tailored to your situation

In-person or telemedicine consultations, anywhere in Quebec.

Anal fissure is a linear tear or longitudinal ulceration of the squamous epithelium of the anal canal, extending from the dentate line to the external anal verge, usually located in the posterior median position (90 % of cases) and more rarely in the anterior position (10 % - more frequent in women after childbirth). It is one of the most frequent causes of acute anal pain in family medicine, with an estimated annual incidence of 1 per 1,000 people. Its pathophysiology is based on a well-established vicious circle: initial trauma to the anal mucosa (hard stool + constipation + diarrhea) → pain → reflex hypertonicity of the internal sphincter of the anus → ischemia of the posterior anal mucosa (the vascularization of the posterior commissure is the least well vascularized of the anal circumference, explaining the posterior predominance of fissures) → delayed healing → chronicization. The acute fissure is a recent superficial tear (6-8 weeks of evolution) present indurated, fibrotic margins, often associated with a hypertrophic papilla upstream (dentate line), a cutaneous cap (sentinel pile or sentinel mariscus) downstream and persistent sphincter hypertonia - they require active medical or surgical treatment. Anal fissures affect all age groups, with peak incidence in young and middle-aged adults (20-40 years), and also affect infants (infant anal fissures - constipation + breast milk/artificial milk transition - almost universal cure with conservative treatment). An anal fissure that is lateral, multiple, recurrent or refractory to treatment should always raise suspicion of a secondary cause: Crohn's disease, anal tuberculosis, HIV infection, syphilis, anal squamous cell carcinoma or leukemia.

Diagnosis, clinical presentation and differential diagnosis

  • Clinical presentation and proctological examination : characteristic symptoms : sharp, stabbing or burning anal pain, typically occurring during defecation and persisting from a few minutes to several hours afterwards (prolonged post-defecatory pain - different from hemorrhoidal pain) - rectorrhagia of small abundance on the toilet paper or in a trickle on the stool (bright red blood - not mixed with the stool) - anal pruritus + permanent anal discomfort in chronic forms - the patient dreads defecation and may deliberately delay bowel movements, thus aggravating constipation (vicious circle) ; clinical examination : anal inspection with gentle spreading of the margins - in the vast majority of cases, the fissure is visible without anoscopy (no need for systematic and painful anoscopy in 1st intention) - Sims position (left lateral decubitus + knee flexion) or genu-pectoral position - fissure margins : clear and sharp (acute fissure) vs. indurated + fibrotic + sentinel mariscus downstream (chronic fissure) - sphincter hypertonicity at edge separation (indirect sign) - fissure is painful to palpation → do not perform rectal touch if fissure visible (unnecessary pain + non-contributory to diagnosis - reserve RT after healing or under local anesthesia); anoscopy: deferred after healing or under local anaesthetic - reserved for atypical cases (lateral fissure + unusual position + suspicion of associated pathology) or to visualize hypertrophic papilla; features suggestive of idiopathic primary fissure: posterior-medial (90 %) or anterior (10 % - female) position + typical post-defecatory pain profile + terrain (constipation + young adult + post-partum) + single fissure + visible fundus + sharp margins (acute) or chronic with sentinel mariscus
  • Secondary cracks - causes not to be missed : ano-perineal Crohn's disease : multiple fissures + lateral position + atypical + fissures with indeterminate background + large, deep ulcerations + purplish inflammatory marisci + fistulae + associated perianal abscesses + not necessarily sphincter hypertonia - antecedent IBD or chronic diarrhea + weight loss + systemic context - colonoscopy + biopsies + fecal calprotectin + CRP + nutritional assessment - medical treatment of IBD in 1st line (corticosteroids + immunosuppressants + antiTNF) - internal lateral sphincterotomy is contraindicated in IBD (risk of severe anal incontinence); secondary or tertiary anal syphilis : painless or only slightly painful anal ulcerations + condylomata lata (large, flat, verrucous plaques) + painless bilateral inguinal adenopathies + syphilis serology (TPHA + VDRL + FTA-Abs) + Treponema pallidum PCR on ulceration swab; anal tuberculosis: anfractuous ulceration + anal fistula + mucoid secretions + immigrant context + immunodepression + IDR + IGRA + biopsy (caseous granulomas); anal squamous cell carcinoma: irregular ulceration + induration + raised edges + bleeding + inguinal ADP + in patient with history of condyloma + HIV + immunodepression + multiple partners - biopsy mandatory; advanced HIV (CD4 <200): extensive anal ulcerations with CMV + HSV - viral cultures + PCR; leukemia and hematological diseases: anal ulcerations in the context of profound neutropenia
  • Differential diagnoses of anal pain : thrombosed internal hemorrhoids: sudden pain + bluish swelling visible on inspection + no linear tear - treatment: urgent surgical excision or conservative treatment (NSAIDs + sitz baths) depending on time since thrombosis; anorectal abscess: pulsatile pain + fever + redness + localized induration - surgical emergency (drainage); anal fistula: chronic purulent discharge + pain - proctology for assessment and surgical treatment; fleeting proctalgia (Thiele syndrome): episodic + nocturnal + brief (seconds to minutes) spastic anal pain without visible lesion - treatment: muscle relaxants + biofeedback; coccygodynia: coccygeal pain + aggravated by sitting; actinic rectitis (after pelvic radiotherapy) + solitary rectal ulceration; anal dermatosis (psoriasis + lichen planus + lichen sclero-atrophic + contact dermatitis).

Treatment

TreatmentMechanism, products and terms and conditionsEfficacy, results and precautions
Conservative treatment, 1st line
Acute and chronic fissures - Hygienic and dietary measures
Le traitement conservateur est la base de la prise en charge de toute fissure anale, il est proposé en première intention dans les fissures aiguës et en association avec les traitements pharmacologiques dans les fissures chroniques ; régularisation du transit intestinal (mesure fondamentale) : objectif : selles molles, formées, sans effort de poussée, augmentation des apports en fibres alimentaires (25–35 g/j) : fruits + légumes + légumineuses + céréales complètes, augmentation des apports hydriques (1,5–2 L/j), suppléments de fibres solubles si apports insuffisants : psyllium (Métamucil) 1 càs dans 250 mL d'eau × 2–3/j ou methylcellulose (Citrucel) + augmentation progressive pour éviter les flatulences, laxatifs osmotiques (polyéthylène glycol, PEG, Restoralax 17 g/j dans 240 mL eau × 1/j) ou macrogol (Lax-A-Day) si constipation installée, lactulose 15–30 mL × 1–2/j (alternative), objectif transit : 1 selle molle/j sans effort ; bains de siège (sitz baths) : immersion des fesses et du périnée dans de l'eau tiède (36–38 °C) × 15–20 min × 2–4 fois/j + après chaque selle, mécanisme : relaxation du sphincter interne (réduction réflexe de l'hypertonie sphinctérienne) + amélioration de la circulation locale + soulagement antalgique direct, eau simple sans additif, ajouter du sel de mer ou bicarbonate de soude si souhait de la patiente mais pas de bénéfice démontré au-delà de l'eau simple chaude, sécher délicatement par tamponnement (ne pas frotter) ; antalgiques locaux et systémiques : crème ou suppositoire anesthésiant topique : lidocaïne 2–5 % gel ou crème (Xylocaïne), application 15–30 min avant la défécation + après la selle + au coucher, soulagement antalgique local permettant une défécation moins douloureuse, benzocaïne topique (crème Anusol + Preparation H + autres combinaisons), attention : allergie possible aux anesthésiques locaux (benzocaïne), durée : maximum 2–4 semaines (risque de dermite de contact par utilisation prolongée) ; acétaminophène 500–1 000 mg × 4/j + AINS (ibuprofène 400 mg × 3/j) PO pour la douleur post-défécatoire, éviter les opioïdes (constipation aggravée) Healing rate of conservative treatment alone: acute fissure (duration <6 weeks): spontaneous healing under conservative treatment in 40-50 % of cases at 6-8 weeks - conservative treatment is sufficient as first-line treatment in all acute fissures; chronic fissure under conservative treatment alone (fibers + laxatives + sitz baths + local anesthetics): healing in 20-40 % of cases at 8-12 weeks depending on series - insufficient rate for chronic fissures → need for active topical pharmacological treatment (nitroglycerin or diltiazem or nifedipine) in combination; results of sitz baths - meta-analysis Lund et al. 2006: no difference in efficacy between simple warm water vs. water with additives - sitz baths improve comfort and reduce post-defecatory pain, but do not statistically significantly increase cure rates compared to other active measures - they remain indicated as a basic comfort measure; regularization of intestinal transit: measure with the greatest long-term impact - prevention of recurrences in 70-80 % of cases if transit is durably normalized - fissure treatment must always be accompanied by long-term transit management (diet + hydration + physical activity) to prevent recurrences
Topical nitro derivatives - nitroglycerin
Chemical sphincterotomy - 1st line pharmacology
Les dérivés nitrés topiques (nitroglycérine, glycéryle trinitrate, GTN) constituent le traitement pharmacologique de 1re ligne de la fissure anale chronique dans la plupart des guidelines internationaux (ASCRS + ESCP) ; mécanisme d'action : libération d'oxyde nitrique (NO) localement → relaxation du muscle lisse du sphincter interne → réduction de la pression de repos du canal anal (hypertonie sphinctérienne) → amélioration de la perfusion de la muqueuse anale postérieure ischémique → cicatrisation de la fissure ; formulation et posologie : pommade de nitroglycérine 0,2 % (GTN 0,2 %), au Canada, la pommade de nitroglycérine à 0,2 % n'est pas disponible sous forme commerciale préparée en routine, elle est préparée par des pharmacies préparatrices (préparations magistrales) ou substituée par les diltiazem/nifédipine topiques disponibles au Canada, application d'une noisette de pommade (1–1,5 cm = environ 375–500 µg) sur la marge anale et le canal anal distal × 2–3/j pendant 6–8 semaines, application avec le doigt ou un coton-tige ; effets indésirables principaux : céphalées (les plus fréquentes, surviennent dans 20–65 % des patients, dose-dépendantes, souvent limitantes pour l'observance) + hypotension orthostatique + flush, réduction à 0,1 % si céphalées intolérables, prendre le traitement en position couchée, débuter à une application le soir au coucher pour limiter les céphalées initiales, CI absolue : association aux inhibiteurs de la phosphodiestérase de type 5 (sildenafil + tadalafil + vardénafil) → hypotension sévère ; durée du traitement : 6–8 semaines, réévaluation à 8 semaines, en cas de récidive après arrêt : nouvelle cure possible Efficacy of topical nitroglycerin - meta-analyses (Sanei et al. - Dis Colon Rectum 2009 + Cochrane Review 2012): chronic fissure healing rate at 8 weeks: 49-68 % on GTN 0.2-0.4 % vs. 30-40 % on placebo - reduction in internal sphincter resting pressure of 25-35 % on GTN - recurrence after discontinuation: 30-40 % at 1 year (nitroglycerin treats the symptom but does not correct the terrain); comparison GTN vs topical diltiazem: meta-analysis Nelson et al. - Cochrane 2012: comparable efficacy of GTN and topical diltiazem on cure rates - diltiazem is better tolerated (fewer headaches) → preference for diltiazem in Canada where both formulations are available in magistral preparations; comparison GTN vs botulinum toxin: meta-analysis Sajid et al. - J Gastrointest Surg 2008: slightly higher cure rate with botulinum toxin (73 % vs. 60 %) + fewer recurrences (18 % vs. 42 % at 1 year) but more invasive and costly injection procedure - botulinum toxin is reserved for 2nd-line treatment after failure of topicals in most therapeutic algorithms; availability of nitrate preparations in Quebec: nitroglycerin 0.2 % or 0.4 % ointment available on prescription from compounding pharmacies or certain hospital pharmacies in Quebec - prescription stating «magistral preparation: nitroglycerin 0.2 % rectal ointment - 30 g».»
Topical calcium channel blockers - diltiazem and nifedipine
Better-tolerated alternative to nitroglycerin
Topical calcium channel blockers (diltiazem 2 % and nifedipine 0.2-0.3 %) represent the main pharmacological alternative to nitroglycerin - they are often preferred as 1st-line therapy in Canada due to their better tolerability (fewer headaches) and comparable efficacy; mechanism of action: inhibition of sphincter smooth muscle voltage-dependent calcium channels → reduction of intracellular calcium influx → relaxation of the internal sphincter → reduction of anal resting pressure → improvement of ischemic perfusion → healing; topical diltiazem 2 % ointment or gel: application of a hazelnut × 2/d to the anal margin and distal anal canal - duration: 6-8 weeks - available in compounding form from Quebec compounding pharmacies - adverse effects: mild (transient local burns + rare mild headaches <10 % vs. 20-65 % for GTN) + little systemic effect at these topical doses - no known major contraindication to this topical dose; topical nifedipine 0.2-0.3 % ointment: same mechanism + similar effects - less widely used than diltiazem in Canada - available in compounding; oral diltiazem (Cardizem): also used in certain cases of chronic fissure refractory to topicals or if topicals unavailable - 60 mg × 2/d PO × 8 weeks - efficacy equivalent to topicals - more marked systemic side effects (headache + flush + edema of lower limbs + bradycardia) - side effect profile less favorable than topical diltiazem → prefer topical route; oral nifedipine 20 mg × 2/d PO × 8 weeks: alternative if topical unavailable - same reservations on systemic effects Evidence for topical diltiazem: randomized trial Knight et al. - Br J Surg 2001: diltiazem 2 % topical vs nitroglycerin 0.2 % topical × 8 weeks - cure rate: diltiazem 65 % vs GTN 68 % (non-significant difference) - headache: diltiazem 6 % vs GTN 38 % → clear superiority of diltiazem on tolerance for equivalent efficacy; meta-analysis Sajid et al. - Tech Coloproctol 2008: topical diltiazem compared with internal lateral sphincterotomy (SLI): cure rate at 6-8 weeks: SLI 89 % vs diltiazem 65 % - but post-SLI anal incontinence: 0-30 % → role of diltiazem as a less invasive 1st-line treatment well validated, reserving SLI for failures; place in the algorithm in Quebec: topical diltiazem 2 % has become the 1st-line pharmacological treatment for chronic fissures in the majority of Quebec practices due to its better tolerability and equivalent efficacy to GTN - magistral preparations readily available in compounding pharmacies in major centers (Montreal + Quebec + Sherbrooke + Laval) on medical prescription; optimal duration of treatment and decision to move to 2nd line: if no cure (persistence of pain + absence of healing on inspection) after 8 weeks of well-administered topical treatment → indication for 2nd line: botulinum toxin (injection by proctologist) or internal lateral sphincterotomy (surgery)
Botulinum toxin (Botox)
2nd line - chronic fissure refractory to topicals
Injection of botulinum toxin type A (Botox - onabotulinum toxin A) into the internal sphincter of the anus is the reference 2nd-line treatment for chronic fissures refractory to topical medical therapy - performed in consultation or in the operating room (under local or light general anesthesia depending on patient cooperation) by a colorectal surgeon or proctologist; mechanism of action: botulinum toxin type A → inhibition of acetylcholine release at neuromuscular junctions → reversible chemical paralysis of the internal sphincter of the anus → reduction of anal resting pressure by 25-35 % → lifting of sphincter hypertonia → improvement of ischemic perfusion → healing of the fissure → duration of effect: 3-6 months (then gradual recovery of sphincter function); dosage and technique: 20-50 IU of Botox (onabotulinum toxin A) injected into the internal sphincter at the level of the fissure or on either side of the posterior commissure - some protocols use 50-100 IU divided into 2-4 injections - fine needle (25G) under visual or ultrasound guidance in consultation (without systematic general anesthesia if patient cooperates) - 5-10 min procedure; adverse effects: transient anal incontinence (gas + loose stools) in 1-10 % of cases, depending on dose (always transient and reversible in 3-6 months) - local hematoma + moderate pain at injection site (24-48h) + rare gluteal abscess - permanent incontinence rate : virtually nil with recommended doses (<50 IU); results and recurrences: cure at 6-8 weeks: 60-80 % - recurrence at 1 year: 30-40 % after a first injection - 2nd injection in case of recurrence effective in 60-70 % of recurrences - good alternative to surgical sphincterotomy in patients at high risk of incontinence (women with a history of difficult childbirth + impaired anal sphincter + anorectal manometry showing low pressure) Evidence for botulinum toxin in chronic anal fissure: randomized trial Maria et al - NEJM 1998: single injection of 20 IU botulinum toxin vs saline injection - healing at 2 months: 73 % vs 13 % - reduction in anal resting pressure of 26 %; meta-analysis Sajid et al. - Int J Colorectal Dis 2011: comparison botulinum toxin vs internal lateral sphincterotomy (SLI): cure rate: botulinum toxin 73 % vs SLI 89 % - anal incontinence: botulinum toxin 0-3 % vs SLI 0-30 % - conclusion: botulinum toxin is slightly less effective than SLI, but has a very superior sphincter safety profile - recommended as 1st-line treatment for patients at risk of incontinence (women + low manometry + history of anal surgery); available in Quebec : botulinum toxin injection for anal fissure available in proctology and colorectal surgery consultations at quaternary hospitals (CHUM + Maisonneuve-Rosemont + CHU de Québec) + some private colorectal surgery clinics - waiting time in public settings: 3-12 months - faster access in private clinics; RAMQ reimbursement: Botox is not reimbursed by RAMQ for anal fissure indication - cost of private procedure: 500-1,500 $ depending on center and anesthesia used
Lateral internal sphincterotomy (SLI)
Surgery - definitive treatment - refractory fissure
Lateral internal sphincterotomy (LIS) is the gold-standard surgical procedure for chronic refractory anal fissure - it involves controlled partial sectioning of the internal sphincter of the anus to permanently reduce sphincter hypertonicity and allow fissure healing; surgical technique: performed under general anesthesia or spinal anesthesia in outpatient surgery (one-day surgery in the majority of cases) - closed route (most common technique): section of the internal sphincter through a lateral incision (3 o'clock or 9 o'clock position on the time dial) without opening the anal canal - open route (less frequently used): lateral incision with direct visualization of the sphincter before section; extent of section: section of the internal sphincter over a height equal to the height of the fissure («fissure-height» section - tailored sphincterotomy) or section up to the dentate line - section limited to the height of the fissure reduces the risk of incontinence compared with traditional sphincterotomy up to the dentate line; usual post-operative course: moderate post-operative pain (acetaminophen + NSAIDs) - slight bleeding per-operatively and immediately post-operatively - return home the same day - return to work: 1-2 weeks for sedentary professions + 3-4 weeks for physical professions - post-operative sitz baths recommended × 4-6 weeks; fissulectomy (removal of the fissure): can be combined with SLI in very chronic fissures (thick fibrosis + bulky sentinel mucosa + hypertrophic papilla) - mucosal advancement flap: alternative to SLI in normal- or low-pressure fissures (Crohn's + post-partum + patients at high risk of incontinence) - covers fissure with a flap of healthy mucosa without sphincter transection Results of internal lateral sphincterotomy: cure rate of chronic fissure: 89-95 % at 6-8 weeks (the most effective treatment available) - long-term recurrence: 3-8 % at 5 years - SLI has the best cure rate of all available treatments and the lowest recurrence rate; risk of post-SLI anal incontinence: data from meta-analysis Mentes et al. + Cochrane Review 2011 - total incontinence (solid stool): <1 % - gas or liquid stool incontinence (soiling): 0-30 % depending on series and techniques - recent studies with sphincterotomy limited to the height of the fissure (tailored SLI) report a significant incontinence rate of 5-10 % in the long term - risk increases with advanced age + multiparous women + history of obstetrical trauma + patients with low sphincter pressure on anorectal manometry → these patients must be informed of the risk + preoperative anorectal manometry systematically recommended before SLI in multiparous women; preoperative evaluation recommended : anorectal manometry (measurement of anal sphincter resting and maximum compression pressure) + endoanal ultrasound (measurement of sphincter thickness + search for sphincter defects) → if sphincter defect present or low pressure → relative contraindication to SLI → prefer rectal flap advancement or botulinum toxin; formal contraindications to SLI: ano-perineal Crohn's disease (risk of severe irreversible incontinence + non-healing) + known sphincter defect + low sphincter pressure on manometry (increased risk of incontinence)
ℹ️ Anal fissure in infants and children: anal fissure is common in infants (2-4 months) during dietary diversification or when switching from breast milk to formula, and in children suffering from functional constipation. It manifests itself as crying during defecation, minimal rectorrhagia on the diaper and refusal to go to the toilet. Treatment is exclusively conservative: regularization of transit with breast milk or hydration + pediatric polyethylene glycol (Restoralax 0.5-1 g/kg/d) + local anesthetic cream before diaper changes + sitz baths - recovery is almost universal within a few weeks without surgical intervention. Sphincterotomy and botulinum toxin are not indicated in children. A recurrent or refractory anal fissure in a child should prompt a search for severe functional constipation (megacolon) or Hirschsprung's disease.
Signs requiring rapid medical assessment

Anal fissure + fever + throbbing pain + perianal induration → associated perianal abscess → urgent surgical consultation - abscess drainage can't wait.

Lateral + multiple + recurrent + fissure in an immunocompromised patient or one with chronic diarrhea → secondary fissure to be suspected (Crohn's + HIV + tuberculosis + syphilis) → oriented workup + colonoscopy + serologies.

Significant rectal pain (more than a trickle on paper) + anal pain with no visible fissure on inspection → differential cause to be ruled out (thrombosed hemorrhoids + rectal cancer + rectitis) → medical consultation without delay.

Consult at Clinique Omicron

À Clinique Omicron, une consultation médicale permet d'évaluer la fissure anale, de proposer le traitement et les conseils pour soulager la douleur, puis d'assurer le suivi. Selon votre situation, une orientation vers un chirurgien colorectal ou un gastroentérologue peut être faite. Consultations en clinique ou en téléconsultation. Au moment de réserver, indiquez le motif de votre consultation. Pour faire une demande de rendez-vous, Choose your online service.

The content of this page is provided for information purposes only and does not replace the advice of a qualified healthcare professional. Chronic anal fissure or anal fissure refractory to medical treatment should be evaluated by a colorectal surgeon or proctologist.

Omicron Clinic

Need to consult a doctor?

In-person or via telemedicine, anywhere in Quebec.

We accept insurance. Telemedicine consultations available 7 days a week. No family doctor required.